OTCMKTS:BVNRY - Bavarian Nordic A/S Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$10.84
▼ -0.36 (-3.22%)

This chart shows the closing price for BVNRY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Bavarian Nordic A/S Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BVNRY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BVNRY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for Bavarian Nordic A/S in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a -100.00% upside from the last price of $10.84.

This chart shows the closing price for BVNRY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 2 investment analysts is to hold stock in Bavarian Nordic A/S.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/12/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/12/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/9/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/7/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/7/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/6/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/6/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/4/2022CowenDowngradeOutperform ➝ Market Perform
12/22/2021UBS GroupDowngradeBuy ➝ Neutral
9/15/2017Maxim GroupDowngradeBuy ➝ Hold
9/15/2017Maxim GroupReiterated RatingBuy ➝ Hold
(Data available from 7/7/2017 forward)

News Sentiment Rating

0.23 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/9/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/8/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/7/2022
  • 4 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/9/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/8/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/8/2022
  • 6 very positive mentions
  • 21 positive mentions
  • 3 negative mentions
  • 3 very negative mentions
6/7/2022
  • 6 very positive mentions
  • 22 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
7/7/2022

Current Sentiment

  • 6 very positive mentions
  • 22 positive mentions
  • 4 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Bavarian Nordic A/S logo
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. The company operates in the United States, Belgium, Germany, the Netherlands, Sweden, Switzerland, Austria, the United Kingdom, Japan, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
Read More

Today's Range

Now: $10.84
Low: $10.74
High: $11.05

50 Day Range

MA: $9.19
Low: $6.19
High: $11.54

52 Week Range

Now: $10.84
Low: $5.85
High: $19.25

Volume

93,363 shs

Average Volume

54,663 shs

Market Capitalization

$2.29 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22

Frequently Asked Questions

What sell-side analysts currently cover shares of Bavarian Nordic A/S?

The following Wall Street analysts have issued research reports on Bavarian Nordic A/S in the last twelve months: Cowen Inc, and UBS Group AG.
View the latest analyst ratings for BVNRY.

What is the current price target for Bavarian Nordic A/S?

0 Wall Street analysts have set twelve-month price targets for Bavarian Nordic A/S in the last year.
View the latest price targets for BVNRY.

What is the current consensus analyst rating for Bavarian Nordic A/S?

Bavarian Nordic A/S currently has 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in BVNRY, but not buy more shares or sell existing shares.
View the latest ratings for BVNRY.

How do I contact Bavarian Nordic A/S's investor relations team?

Bavarian Nordic A/S's physical mailing address is Hejreskovvej 10A, Kvistgaard G7, 3490. The company's listed phone number is (453) 326-8383 and its investor relations email address is [email protected] The official website for Bavarian Nordic A/S is www.bavarian-nordic.com. Learn More about contacing Bavarian Nordic A/S investor relations.